Vesna Pavasovic

Great Ormond Street Hospital For Children
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Late Onset Blinatumomab-Related Neurotoxicity in a Child With B-Cell Acute Lymphoblastic Leukemia.

Late Onset Blinatumomab-Related Neurotoxicity in a Child With B-Cell Acute Lymphoblastic Leukemia.

Journal: Pediatric blood & cancer

Published: June 03, 2025

Nephrotoxicity Surveillance for Childhood and Young Adult Survivors of Cancer: Recommendations From the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Nephrotoxicity Surveillance for Childhood and Young Adult Survivors of Cancer: Recommendations From the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 20, 2025

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial.

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial.

Journal: Pediatric blood & cancer

Published: March 27, 2025

Long-term outcomes of genome-edited "universal" CAR19 T cells for relapsed/refractory B-ALL at a single pediatric center.

Long-term outcomes of genome-edited "universal" CAR19 T cells for relapsed/refractory B-ALL at a single pediatric center.

Journal: Blood advances

Published: March 03, 2025

Late Adverse Effects after Treatment for Childhood Acute Leukemia.

Late Adverse Effects after Treatment for Childhood Acute Leukemia.

Journal: Acta medica academica

Published: January 21, 2024

Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.

Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.

Journal: Blood cancer journal

Published: December 01, 2023

Benefits for children with suspected cancer from routine whole-genome sequencing.

Benefits for children with suspected cancer from routine whole-genome sequencing.

Journal: Nature medicine

Published: November 20, 2023

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy.

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy.

Journal: Blood advances

Published: July 10, 2023

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.

Journal: Blood

Published: March 31, 2023

Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Journal: The Lancet. Oncology

Published: October 13, 2022

What is the diagnostic yield of bone marrow aspiration to exclude leukaemia prior to systemic treatment in juvenile idiopathic arthritis?

What is the diagnostic yield of bone marrow aspiration to exclude leukaemia prior to systemic treatment in juvenile idiopathic arthritis?

Journal: British journal of haematology

Published: June 30, 2022

Blinatumomab for paediatric mixed phenotype acute leukaemia.

Blinatumomab for paediatric mixed phenotype acute leukaemia.

Journal: British journal of haematology

Published: July 13, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026